216 related articles for article (PubMed ID: 17597186)
1. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
Poli D; Antonucci E; Marcucci R; Fatini C; Alterini B; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
Thromb Res; 2007; 121(3):347-52. PubMed ID: 17597186
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
3. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
J Am Coll Cardiol; 2009 Sep; 54(11):999-1002. PubMed ID: 19729116
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
Abdelhafiz AH; Wheeldon NM
Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
[TBL] [Abstract][Full Text] [Related]
6. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
7. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N
Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
[TBL] [Abstract][Full Text] [Related]
10. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
12. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
[TBL] [Abstract][Full Text] [Related]
13. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
14. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299
[TBL] [Abstract][Full Text] [Related]
15. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
[TBL] [Abstract][Full Text] [Related]
16. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
[TBL] [Abstract][Full Text] [Related]
18. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
